What was the origin of the "napkin experiment" mentioned in the podcast?

The "napkin experiment" originated from a dinner conversation between Siddhartha Mukherjee and Luc Antley approximately five years before the podcast. An idea sketched on a napkin that evening evolved into a significant scientific collaboration and research paper concerning cancer metabolism.

Why is 'The Emperor of All Maladies' considered a clarifying book rather than depressing?

Mukherjee views 'The Emperor of All Maladies' as clarifying because it directly confronts the history and nature of cancer, an 'enemy.' He highlights the book's numerous high points, such as surgical advances and dramatic improvements in leukemia survival rates, as reasons it's not a depressing read.

What prompted Siddhartha Mukherjee to write 'The Emperor of All Maladies'?

While treating a patient, Mukherjee was asked, 'Where are we going with all of this? Why are we here?' This question inspired him to explore the history of cancer, seeing a lack of cohesive historical narrative and a desire to understand the journey against the disease.

What are Siddhartha Mukherjee's core principles for writing?

Mukherjee follows two main tenets: no scientific abstraction without a human being central to the narrative and ensuring the books are readable by everyone, like a kaleidoscope offering different perspectives. He emphasizes bridging the gap between the lab and human experience.

What are the Three Laws of Medicine proposed by Siddhartha Mukherjee?

The three laws are: 1. A strong intuition is much more powerful than a weak test. 2. Normals teach us rules, outliers teach us laws. 3. For every perfect or exceptional medical experiment, there is a human bias that goes along with it.

How does Siddhartha Mukherjee explain the role of obesity in cancer?

Mukherjee notes that obesity has become one of the leading preventable causes of cancer, second only to smoking. While not a traditional chemical carcinogen, it's linked through mechanisms like hyperinsulinemia and inflammation, and its impact is becoming increasingly clear.

Why were the Nobel Prize-winning checkpoint inhibitors (CTLA-4, PD-1) significant for cancer therapy?

These inhibitors target specific pathways that cancer cells use to inactivate the immune system. by deactivating these pathways, the immune system can recognize and attack cancer cells, transforming treatment for certain cancers like melanoma and offering durable responses.

What was the key finding of the research on pi3 kinase inhibitors and ketogenic diets?

The study found that pi3 kinase inhibitors could induce a hyperinsulinemic state, which tumors then exploited to become resistant to the drug. Combining the drug with a ketogenic diet paralyzed this resistance mechanism, showing a potential synergistic effect.

Does a ketogenic diet prevent cancer or treat it on its own?

No, the study demonstrated that a ketogenic diet combined with specific drugs was effective, not the diet alone for cancer treatment. In some cancer models, the keto diet alone even accelerated growth. The research is ongoing to understand its preventative role separately.

What is the relationship between Gleevec and targeted cancer therapy?

Gleevec is a prime example of targeted therapy. Scientists identified the specific gene product (BCR-ABL) driving chronic myeloid leukemia and developed a drug to jam that specific 'engine,' effectively treating the cancer without harming normal cells.

How does Siddhartha Mukherjee approach his diverse work in writing, research, and medicine?

He describes himself as question and project-driven. His approach involves putting an idea or experiment out into the world and then persistently refining it, while remaining open to when the work 'speaks back.' He sees writing and science as integrated parts of his thinking process.

Key Moments

#32–Siddhartha Mukherjee, M.D., Ph.D.: new frontiers in cancer therapy, medicine, and writing

Peter Attia MD

People & Blogs3 min read66 min video

Jan 7, 2020|3,419 views|73|8

Save to Pod

Key Moments

TL;DR

Siddhartha Mukherjee discusses cancer therapy, writing, and the "Laws of Medicine" on Peter Attia's podcast.

Key Insights

The history and evolving understanding of cancer, from "The Emperor of All Maladies" to current research.

The integration of writing and science as a process of thinking and making complex topics accessible.

The "Laws of Medicine": intuition vs. testing, outliers as teachers, and bias in experimentation.

Immunotherapy's evolution, particularly checkpoint inhibitors, and their impact on cancer treatment.

The promising, yet complex, intersection of metabolism, diet, and cancer therapy, as seen in a study combining ketogenic diets with pi3 kinase inhibitors.

The importance of making scientific progress by planting the "first stake" in a problem, enabling further linear research.

THE JOURNEY OF CANCER RESEARCH AND WRITING

Siddhartha Mukherjee, a physician and Pulitzer Prize-winning author, shares his perspective on the history and evolution of cancer research. His work, including "The Emperor of All Maladies," aims to provide a comprehensive narrative of the battle against cancer, highlighting significant advances in surgery, chemotherapy, and more recently, immunotherapy. Mukherjee emphasizes that understanding the history of cancer is not a depressing endeavor but rather a clarifying one, offering insights into our progress and future directions in fighting the disease. He also discusses the genesis of his book, sparked by a patient's question about the trajectory of cancer treatment.

BALANCING SCIENCE AND STORYTELLING

Mukherjee views writing not as a separate pursuit but as an integral part of his scientific thinking process. He adheres to principles like ensuring human stories are woven into scientific narratives, making complex topics accessible to a broad audience. His approach transforms scientific concepts into relatable narratives, illustrated by the example of explaining oncogenes by connecting laboratory discoveries to patient experiences. This integration allows for a deeper understanding and broader appeal, making science impactful beyond the research community.

THE THREE LAWS OF MEDICINE

Mukherjee introduces "The Three Laws of Medicine," derived from Bayesian principles and observations on scientific practice. The first law posits that a strong intuition is more powerful than a weak test, emphasizing the value of prior information (priors) in interpreting data. The second law highlights that outliers teach us laws, while normals teach us rules, suggesting that rare cases often reveal fundamental biological principles. The third law states that for every perfect or exceptional medical experiment, there is an intrinsic human bias, stressing the need for skepticism and self-awareness in research and clinical practice.

THE REVOLUTION OF IMMUNOTHERAPY

The discussion delves into the significant advancements in cancer immunotherapy, particularly the development of checkpoint inhibitors like CTLA-4 and PD-1. Mukherjee explains how these therapies work by releasing the brakes on the immune system, allowing it to recognize and attack cancer cells. He notes the Nobel Prize awarded for this work, underscoring its transformative impact. While immunotherapy has led to durable responses in some patients, challenges remain, such as understanding why certain tumors respond and why some patients relapse, driving further research into resistance mechanisms.

METABOLIC THERAPY AND CANCER

A key focus is the collaborative research on combining ketogenic diets with PI3K inhibitors. This study, initially sketched on a napkin, explored how metabolic states affect cancer. The research found that certain cancer drugs can induce a hyperinsulinemic state, which tumors exploit to become resistant. Combining these drugs with a ketogenic diet paralyzed this resistance in animal models. Mukherjee stresses that this is an animal study, not a recommendation for home use, and that the role of ketogenic diets in cancer prevention or treatment requires further rigorous investigation.

THE FUTURE OF ONCOLOGY: PRECISION AND PERSPECTIVE

Mukherjee elaborates on the shift towards more personalized and systemic approaches in cancer treatment. He draws parallels between the systemic assault of immunotherapy and the current metabolic research, suggesting these methods are less about targeting specific mutations (like Gleevec) and more about broad interventions. The research indicates that these approaches can be mutation-agnostic, offering new hope for challenging cancers. The concept of planting the 'first stake' in a problem, whether through immunotherapy or metabolic intervention, is crucial for transforming complex, non-linear problems into linear, addressable research pathways.

Mentioned in This Episode

●Software & Apps

●Organizations

●Books

●Drugs & Medications

●Concepts

●People Referenced

Common Questions

Siddhartha Mukherjee is a Pulitzer Prize-winning writer, physician, and scientist. He is renowned for his books, including 'The Emperor of All Maladies: A Biography of Cancer' and 'The Gene: An Intimate History,' which explore complex scientific topics with compelling narrative.

Topics

Health & Longevity Science & Mathematics Medical Ethics Cancer Research Cancer Therapy Medicine & Clinical Metabolic Oncology Bayesian Thinking Scientific Writing Obesity And Cancer

Mentioned in this video

Organizations

The New Yorker

Publication where Siddhartha Mukherjee consistently publishes his writing.

Nature

Scientific journal where Siddhartha Mukherjee has published.

Oxford University

University where Siddhartha Mukherjee earned his PhD in immunology.

Harvard Medical School

Institution where Siddhartha Mukherjee earned his MD.

Stanford University

Institution where Siddhartha Mukherjee studied biology for his undergraduate degree.

Columbia University

Institution where Siddhartha Mukherjee is an associate professor of medicine and where the interview took place.

New England Journal of Medicine

Medical journal where Siddhartha Mukherjee has published.

New York Times

Publication where Siddhartha Mukherjee consistently publishes his writing.

Dana Farber Cancer Institute

Institution where Peter Atia's friend is undergoing treatment and where Siddhartha Mukherjee did his fellowship.

Books

The Three Laws of Medicine

A short book by Siddhartha Mukherjee commissioned by TED, outlining three fundamental principles for thinking in medicine.

The Gene

Another book written by Siddhartha Mukherjee, which was also being adapted into a film by Ken Burns.

Emperor of All Maladies

Siddhartha Mukherjee's Pulitzer Prize-winning book, a history of cancer, praised for its storytelling and readability across different audiences.

Concepts

PD-1

A checkpoint inhibitor target in immunotherapy, recognized with a Nobel Prize for its role in cancer treatment.

Immunology

Siddhartha Mukherjee's field of PhD study, and a subject he has returned to in his research.

Ketogenic diets

Dietary approach discussed in the context of cancer therapy, notably in combination with pi3 kinase inhibitors in a study by Mukherjee and Antley.

CTLA-4

One of the checkpoint inhibitor targets in immunotherapy, recognized with a Nobel Prize for its role in cancer treatment.

Her2-neu

A protein often overexpressed in breast cancer, relevant to a friend of Peter Atia undergoing treatment.

PR negative

A classification for breast cancer indicating the absence of progesterone receptors, relevant to a friend of Peter Atia undergoing treatment.

ER positive

A classification for breast cancer indicating the presence of estrogen receptors, relevant to a friend of Peter Atia undergoing treatment.

People

Oliver Sacks

Mentioned as an example of a person who wrote to think, similar to Siddhartha Mukherjee's approach.

Richard Feynman

Physicist and Nobel laureate, admired by Siddhartha Mukherjee and cited for his quote about not fooling oneself.

Charles Darwin

Mentioned as an example of a person who wrote to think, similar to Siddhartha Mukherjee's approach.

Bob Weinberg

A scientist whose story is used to illustrate the human element in scientific discovery, specifically in identifying cancer-causing oncogenes.

Atul Gawande

Mentioned as an example of a person who likely writes to think, similar to Siddhartha Mukherjee's approach.

Luc Antley

A friend of Peter Atia who set up the initial meeting between Atia and Siddhartha Mukherjee, and a collaborator on a significant paper.

Thomas Bayes

Mathematician and economist whose work on probability led to Bayesian inference, a concept discussed in relation to medical diagnosis and decision-making.

Siddhartha Mukherjee

Guest, Pulitzer Prize-winning writer, physician, and scientist specializing in hematology and oncology. He discusses cancer therapy, medicine, and writing.

Brian Druker

Mentioned as one of the key figures in the discovery and development of the drug Gleevec.

Otto Warburg

Pioneering scientist who first hypothesized that cancer cells metabolize differently from normal cells.

Supplements

PI3-Kinase Inhibitors

A class of drugs developed based on Luc Antley's work, showing promise but also resistance, which was studied in combination with ketogenic diets.

Products

Gleevec

A targeted therapy drug for chronic myelogenous leukemia and GIST, which jams the 'engine' of the cancer cell (BCR-ABL).

condition

Triple-negative breast cancer

A particularly challenging type of breast cancer with few treatment options, chosen for study in the new human trial.

Endometrial Cancer

One of the cancer types being studied in the new human trial combining pi3 kinase inhibitors and ketogenic diets.

Lynch syndrome

A genetic disorder that increases the risk of various cancers, and makes patients more susceptible to checkpoint inhibitors.

Software & Apps

BCR-ABL

An oncogene product that functions as a manic engine driving the proliferation of blood cells in chronic myelogenous leukemia.

Found this useful? Build your knowledge library

Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.

Try Summify free